OBJECTIVE: The female preponderance of meningiomas may reflect hormonal influ ences on meningioma growth. We hypothesized that because obesity affects male steroid hormone synthesis, male patients with meningiomas might exhibit a high obesity rate, which, in turn, might increase their frequency of postoperative complications. METHODS: We retrospectively reviewed male patients who underwent craniotomy for benign meningiomas at our institution between 2001 and 2005 (n = 32) and used male patients undergoing craniotomy for aneurysms (n = 32) or glioblastomas (n = 32) from 2001 to 2005 as control subjects. Body mass index (BMI greater than 30 kg/m(2) was considered obese. RESULTS: Male patients with meningiomas had a higher average BMI (30.2 kg/m(2)) 9 than male patients with aneurysms (BMI = 27.5 kg/m(2)) or gliomas (BMI = 25.9 kg/m(2)) (P = 0.04). The obesity rate in men with meningiomas (47%) exceeded that in men with aneurysms (19%) or gliomas (3%) (P = 0.2). The median age-normalized BMI percentile was greater in men with meningiomas (67th percentile) than in men with aneurysms (49th percentile) or gliomas (52nd percentile) (P = 0.02). Deep vein thrombosis/pulmonary embolus was more common in men with meningiomas (19%) than in men with aneurysms (0%) or gliomas (3%) (P = 0.002). Wound infections were more common in men with meningiomas (6%) than in men with aneurysms (3%) or gliomas (0%) (P = 0.2). The 53% of obese patients with meningiomas who were readmitted with postoperative complications exceeded the 18% of nonobese patients with meningiomas who were readmitted (P = 0.03); complications included deep vein thrombosis and pulmonary embolus (27 and 12%, respectively, in obese and nonobese patients with meningiomas) and postoperative fever (53 and 35%, respectively, in obese and nonobese patients with meningiomas). CONCLUSION: We found that many men with meningiomas are obese, suggesting a hormonal influence on meningiomas in men as well as women. Our results also underscore the high risk of postoperative complications in obese male patients with meningiomas.
机构:
King Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
King Saud Univ, Hlth Technol Assessment Unit, Coll Pharm, POB 2457, Riyadh 11451, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Al-Omar, Hussain A.
Alshehri, Ali
论文数: 0引用数: 0
h-index: 0
机构:
King Fahad Med City, Obes Endocrine & Metab Ctr, Obes Med Dept, Riyadh, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Alshehri, Ali
Abanumay, Abdulmohsen
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk, Riyadh, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Abanumay, Abdulmohsen
Alabdulkarim, Hana
论文数: 0引用数: 0
h-index: 0
机构:
Minist Natl Guards Hlth Affairs, Drug Policy & Econ Ctr, Riyadh, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Alabdulkarim, Hana
Alrumaih, Ali
论文数: 0引用数: 0
h-index: 0
机构:
Minist Def, Med Serv Directorate, Pharmaceut Care Dept, Riyadh, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Alrumaih, Ali
Eldin, Mahmoud S.
论文数: 0引用数: 0
h-index: 0
机构:
Novo Nordisk, Riyadh, Saudi ArabiaKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia
Eldin, Mahmoud S.
Alqahtani, Saleh A.
论文数: 0引用数: 0
h-index: 0
机构:
King Faisal Specialist Hosp & Res Ctr, Liver Transplant Ctr, Riyadh, Saudi Arabia
Johns Hopkins Univ, Div Gastroenterol & Hepatol, Baltimore, MD USAKing Saud Univ, Dept Clin Pharm, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia